Modulation of L-arginine transport and nitric oxide production by gabexate mesylate (Q44068283)

29 November 2017

title

Modulation of L-arginine transport and nitric oxide production by gabexate mesylate (English)

1 reference

29 November 2017

author

Maria Grazia Signorello

series ordinal

3

object named as

Maria Grazia Signorello

1 reference

29 November 2017

Giuliana Leoncini

1

1 reference

29 November 2017

Raffaele Pascale

series ordinal

2

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 July 2002

1 reference

29 November 2017

published in

Biochemical Pharmacology

1 reference

29 November 2017

volume

64

1 reference

29 November 2017

issue

2

1 reference

29 November 2017

page(s)

277-283

1 reference

The L-arginine-nitric oxide pathway

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901108-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901108-5

Nitric oxide insufficiency, platelet activation, and arterial thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901108-5

Nitric oxide: an endogenous modulator of leukocyte adhesion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901108-5

The effects of exogenous nitric oxide on smooth muscle cell proliferation following porcine carotid angioplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901108-5

Human neutrophils and mononuclear cells inhibit platelet aggregation by releasing a nitric oxide-like factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901108-5

Nitric oxide-donor compounds inhibit lipoxygenase activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901108-5

Selective inhibition of the 12-lipoxygenase pathway of arachidonic acid metabolism by L-arginine or sodium nitroprusside in intact human platelets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901108-5

Nitric oxide donors activate the cyclo-oxygenase and peroxidase activities of prostaglandin H synthase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901108-5

Isolation of nitric oxide synthase from human platelets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901108-5

Suppression of arthritis by an inhibitor of nitric oxide synthase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901108-5

Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: implications for the treatment of multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901108-5

Paradoxical fate and biological action of peroxynitrite on human platelets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901108-5

Cross-Enzyme Inhibition by Gabexate Mesylate: Formulation and Reactivity Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901108-5

Inhibitory effect of protease inhibitor on endothelial cell activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901108-5

Effect of protease inhibitor on ischemia-reperfusion injury to rat liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901108-5

Inhibitory effect of a synthetic protease inhibitor (gabexate mesilate) on the respiratory burst oxidase in human neutrophils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901108-5

Mechanism of the inhibitory effect of protease inhibitor on tumor necrosis factor alpha production of monocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901108-5

Selective inhibition of human mast cell tryptase by gabexate mesylate, an antiproteinase drug

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901108-5

Regulation of L-arginine uptake by Ca(2+) in human platelets.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901108-5

Effect of 2-(1-piperazinyl)-4H-pyrido[1,2-a]pyrimidin-4-one (AP155) on human platelets in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901108-5

Nitric oxide metabolism and breakdown.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901108-5

Hydrogen peroxide formation in platelets of patients with non-insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901108-5

Nitric oxide in excitable tissues: physiological roles and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901108-5

Molecular mechanisms and therapeutic strategies related to nitric oxide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901108-5

Blood radicals: reactive nitrogen species, reactive oxygen species, transition metal ions, and the vascular system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901108-5

Measurement of nitric oxide and peroxynitrite generation in the postischemic heart. Evidence for peroxynitrite-mediated reperfusion injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901108-5

Effect of gabexate mesylate (FOY), a drug for serine proteinase-mediated diseases, on the nitric oxide pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901108-5

10.1016/S0006-2952(02)01108-5

7 January 2021

Identifiers

DOI

1 reference

29 November 2017

1 reference